"The significant reduction in risk of composite endpoint of heart attack, stroke, or death seen in the SOUL trial in adults with type 2 diabetes highlights the cardiovascular impact of oral semaglutide in adult patients with cardiometabolic conditions such as type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease," said Dr John B Buse, Distinguished Professor of Medicine, Director of UNC Diabetes Care Center, Steering Committee Co-Chair of the SOUL trial
4A, Supplemental Fig
I didnt feel weak or starvedI felt supported. M.R
For the treatment to be effective, it should also be used as a combination with exercise and a healthy, low-calorie diet
Studies, including data from clinical trial observations, have shown elevated serum TSH, anti-thyroid peroxidase, and anti-thyroglobulin antibodies in patients with melasma
Farabegoli F, Barbi C, Lambertini E, Piva R, 2007